Recent News
Insider activity accelerated in March 2026: director-linked entities and affiliated vehicles reported open-market purchases totaling roughly 10,000 shares across several transactions in early–mid March; separate Form 4 filings show additional smaller buys by other directors on March 6. A March 6 Form 4 also records a $16,422 open‑market purchase by a director. These disclosures published in March and February fall within the past 13 weeks and reflect management and director purchases.
Technical Analysis
ADX at 14.25 signals no dominant trend, implying price action may remain range-bound absent a fresh catalyst; directional indicators present mixed signals: DI+ sits at 19.5 and is decreasing (bearish), while DI− sits at 25.23 and shows a peak-and-reversal (bullish), which together imply limited conviction and a tug-of-war between buyers and sellers.
MACD reads 0.63 with the MACD line below the signal line (signal 0.71) and a decreasing MACD trend, indicating waning bullish momentum and a bearish momentum tilt until a MACD crossover reverses that course.
MRO at 31.29 remains positive and decreasing, indicating price sits above the model target and that pressure toward mean reversion exists; the magnitude suggests material downward potential if sellers regain control.
RSI at 56.07 recently completed a dip-and-reversal, signaling renewed buying interest without overbought extremes; that pattern supports further consolidation or modest upside while momentum indicators remain mixed.
Price sits above key averages: last close $52.36 trades above the 200‑day average of $46.01 and above the 20‑day average of $51.56, with the 12‑day EMA at $51.86 recovering after a dip and reversal—these relationships favor upside continuation, but proximity to the upper Bollinger band (~$52.73) limits near-term upside room on a volatility basis.
Ichimoku components place current price above the cloud (Senkou A $47.12 / Senkou B $48.17) with Tenkan at $50.24 and Kijun at $49.48, which supports a bullish bias on a trend-following basis; lower-volume execution (today’s volume ~31,935 vs. 10‑day avg ~43,673) reduces conviction for breakouts.
Fundamental Analysis
Bankwell reported core results covering the period ending March 31, 2026, with the public report filed April 22, 2026; the next scheduled report lists July 22, 2026. The company posted EPS actual $1.41 versus estimate $1.22, an EPS surprise of +15.57%.
Profitability and growth signals present a mixed picture: reported earnings growth stands at 22.61% (most‑recent indicator) while earnings growth QoQ shows −339.27% and earnings growth YoY shows −86.85% (both expressed as percentages), indicating large quarter-level swings that merit attention when parsing sustainability. Revenue growth reads 6.46% overall, but revenue declined QoQ by −33.85% and YoY by −43.22%, underscoring uneven top-line momentum across reporting periods.
Valuation metrics show a P/E of 34.70 and a forward P/E of 34.51; WMDST places the stock as fair-valued. The company’s PEG ratio stands at 1.53, below the industry peer mean of 2.10554 and inside the industry peer range (low −32.03671, high 16.74966), suggesting relative moderation in growth-adjusted valuation versus peers. The company’s P/E sits below the industry peer mean of 54.93915 and within the peer range low of 28.56402 to high of 69.14866. Cost of debt measures roughly 9.37%, and invested capital appears as $-98,280,000 on the balance approach provided. Present cash‑flow‑to‑earnings reads 0%.
Earnings momentum includes a reported EPS beat for the quarter and management-provided materials in an investor presentation dated April 22, 2026; those filings and the investor deck accompany the April report and show management guidance for measured loan growth and targeted net interest income ranges.
Brief valuation note: WMDST values the stock as fair-valued. Relative to peer averages, valuation sits below peer midpoint on a P/E and PEG basis, leaving upside dependent on reacceleration of revenue and more consistent quarter-to-quarter earnings stability.
MOST-RECENT QUARTERLY REPORT
| REPORT PERIOD ENDING: | 2026-03-31 |
| REPORT DATE: | 2026-04-22 |
| NEXT REPORT DATE: | 2026-07-22 |
| CASH FLOW | Begin Period Cash Flow | — |
| Operating Cash Flow | — | |
| Capital Expenditures | — | |
| Change In Working Capital | — | |
| Dividends Paid | — | |
| Cash Flow Delta | — | |
| End Period Cash Flow | — | |
| INCOME STATEMENT | REVENUE | |
| Total Revenue | — | |
| Forward Revenue | — | |
| COSTS | ||
| Cost Of Revenue | — | |
| Depreciation | — | |
| Depreciation and Amortization | — | |
| Research and Development | — | |
| Total Operating Expenses | — | |
| PROFITABILITY | ||
| Gross Profit | — | |
| EBITDA | — | |
| EBIT | — | |
| Operating Income | — | |
| Interest Income | — | |
| Interest Expense | — | |
| Net Interest Income | — | |
| Income Before Tax | — | |
| Tax Provision | — | |
| Tax Rate | — | |
| Net Income | — | |
| Net Income From Continuing Operations | — | |
| EARNINGS | ||
| EPS Estimate | $ 1.22 | |
| EPS Actual | $ 1.41 | |
| EPS Difference | $ 0.19 | |
| EPS Surprise | 15.574 % | |
| Forward EPS | $ 1.40 | |
| BALANCE SHEET | ASSETS | |
| Total Assets | — | |
| Intangible Assets | — | |
| Net Tangible Assets | — | |
| Total Current Assets | — | |
| Cash and Short-Term Investments | — | |
| Cash | — | |
| Net Receivables | — | |
| Inventory | — | |
| Long-Term Investments | — | |
| LIABILITIES | ||
| Accounts Payable | — | |
| Short-Term Debt | — | |
| Total Current Liabilities | — | |
| Net Debt | — | |
| Total Debt | — | |
| Total Liabilities | — | |
| EQUITY | ||
| Total Equity | — | |
| Retained Earnings | — | |
| VALUATION & PER-SHARE METRICS | EQUITY & PER-SHARE METRICS | |
| Book Value Per-Share | — | |
| Shares Outstanding | — | |
| Revenue Per-Share | — | |
| VALUATION | Market Capitalization | — |
| Enterprise Value | — | |
| Enterprise Multiple | — | |
| Enterprise Multiple QoQ | — | |
| Enterprise Multiple YoY | — | |
| Enterprise Multiple IPRWA | — | |
| EV/R | — | |
| CAPITAL STRUCTURE | ||
| Asset To Equity | — | |
| Asset To Liability | — | |
| Debt To Capital | — | |
| Debt To Assets | — | |
| Debt To Assets QoQ | — | |
| Debt To Assets YoY | — | |
| Debt To Assets IPRWA | — | |
| Debt To Equity | — | |
| Debt To Equity QoQ | — | |
| Debt To Equity YoY | — | |
| Debt To Equity IPRWA | — | |
| PRICE-BASED VALUATION | ||
| Price To Book (P/B) | — | |
| Price To Book QoQ | — | |
| Price To Book YoY | — | |
| Price To Book IPRWA | — | |
| Price To Earnings (P/E) | 34.7 | |
| Price To Earnings QoQ | -13.918 % | |
| Price To Earnings YoY | 1.201 % | |
| Price To Earnings IPRWA | high: 69.149 mean: 54.939 median: 37.302 BWFG: 34.7 low: 28.564 |
|
| PE/G Ratio | 1.535 | |
| Price To Sales (P/S) | — | |
| Price To Sales QoQ | — | |
| Price To Sales YoY | — | |
| Price To Sales IPRWA | — | |
| FORWARD MULTIPLES | ||
| Forward P/E | 34.509 | |
| Forward PE/G | 1.526 | |
| Forward P/S | — | |
| EFFICIENCY | OPERATIONAL | |
| Operating Leverage | — | |
| ASSET & SALES | ||
| Asset Turnover Ratio | — | |
| Asset Turnover Ratio QoQ | — | |
| Asset Turnover Ratio YoY | — | |
| Asset Turnover Ratio IPRWA | — | |
| Receivables Turnover | — | |
| Receivables Turnover Ratio QoQ | — | |
| Receivables Turnover Ratio YoY | — | |
| Receivables Turnover Ratio IPRWA | — | |
| Inventory Turnover | — | |
| Inventory Turnover Ratio QoQ | — | |
| Inventory Turnover Ratio YoY | — | |
| Inventory Turnover Ratio IPRWA | — | |
| Days Sales Outstanding (DSO) | — | |
| CASH CYCLE | ||
| Cash Conversion Cycle Days (CCC) | — | |
| Cash Conversion Cycle Days QoQ | — | |
| Cash Conversion Cycle Days YoY | — | |
| Cash Conversion Cycle Days IPRWA | — | |
| CAPITAL DEPLOYMENT | ||
| Cash Conversion Ratio | — | |
| CapEx To Revenue | — | |
| CapEx To Depreciation | — | |
| CAPITAL, LIQUIDITY & COVERAGE | CAPITAL STRUCTURE | |
| Total Capital | — | |
| Net Invested Capital | — | |
| Invested Capital | $ -98.28 M | |
| Net Tangible Assets | — | |
| Net Working Capital | — | |
| LIQUIDITY | ||
| Cash Ratio | — | |
| Current Ratio | — | |
| Current Ratio QoQ | — | |
| Current Ratio YoY | — | |
| Current Ratio IPRWA | — | |
| Quick Ratio | — | |
| Quick Ratio QoQ | — | |
| Quick Ratio YoY | — | |
| Quick Ratio IPRWA | — | |
| COVERAGE & LEVERAGE | ||
| Debt To EBITDA | — | |
| Cost Of Debt | 9.373 % | |
| Interest Coverage Ratio | — | |
| Interest Coverage Ratio QoQ | — | |
| Interest Coverage Ratio YoY | — | |
| Interest Coverage Ratio IPRWA | — | |
| Operating Cash Flow Ratio | — | |
| TIMING / LIQUIDITY | ||
| Days Payables Outstanding (DPO) | — | |
| DIVIDENDS | ||
| Dividend Coverage Ratio | — | |
| Dividend Payout Ratio | — | |
| Dividend Rate | — | |
| Dividend Yield | — | |
| PERFORMANCE | GROWTH | |
| Asset Growth Rate | — | |
| Revenue Growth | 6.46 % | |
| Revenue Growth QoQ | -33.852 % | |
| Revenue Growth YoY | -43.224 % | |
| Revenue Growth IPRWA | high: 22.15 % BWFG: 6.46 % mean: -0.043 % median: -10.249 % low: -16.051 % |
|
| Earnings Growth | 22.609 % | |
| Earnings Growth QoQ | -339.274 % | |
| Earnings Growth YoY | -86.846 % | |
| Earnings Growth IPRWA | BWFG: 22.609 % high: 20.588 % mean: 3.828 % median: -7.273 % low: -22.5 % |
|
| MARGINS | ||
| Gross Margin | — | |
| Gross Margin QoQ | — | |
| Gross Margin YoY | — | |
| Gross Margin IPRWA | — | |
| EBIT Margin | — | |
| EBIT Margin QoQ | — | |
| EBIT Margin YoY | — | |
| EBIT Margin IPRWA | — | |
| Return On Sales (ROS) | — | |
| Return On Sales QoQ | — | |
| Return On Sales YoY | — | |
| Return On Sales IPRWA | — | |
| CASH FLOW | ||
| Free Cash Flow (FCF) | — | |
| Free Cash Flow Yield | — | |
| Free Cash Flow Yield QoQ | — | |
| Free Cash Flow Yield YoY | — | |
| Free Cash Flow Yield IPRWA | — | |
| Free Cash Growth | — | |
| Free Cash Growth QoQ | — | |
| Free Cash Growth YoY | — | |
| Free Cash Growth IPRWA | — | |
| Free Cash To Net Income | — | |
| Cash Flow Margin | — | |
| Cash Flow To Earnings | 0.0 | |
| VALUE & RETURNS | ||
| Economic Value Added | — | |
| Return On Assets (ROA) | — | |
| Return On Assets QoQ | — | |
| Return On Assets YoY | — | |
| Return On Assets IPRWA | — | |
| Return On Capital Employed (ROCE) | — | |
| Return On Equity (ROE) | — | |
| Return On Equity QoQ | — | |
| Return On Equity YoY | — | |
| Return On Equity IPRWA | — | |
| DuPont ROE | — | |
| Return On Invested Capital (ROIC) | — | |
| Return On Invested Capital QoQ | — | |
| Return On Invested Capital YoY | — | |
| Return On Invested Capital IPRWA | — | |